Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Lowering Systolic Blood Pressure Reduces AF Risk

By HospiMedica International staff writers
Posted on 05 Jul 2015
Hypertensive patients that achieve their systolic blood pressure (SBP) target had lower atrial fibrillation (AF) incidence, according to a new study. More...


Researchers at Weill Cornell Medical College (New York, NY, USA), Ulleval Hospital (Oslo, Norway), and other institutions conducted a study to examine the risk of new-onset AF in relation to last in-treatment SBP before AF diagnosis. The study included 8,831 hypertensive patients with left ventricular hypertrophy and no history of AF, who were randomly assigned to losartan- or atenolol-based treatment. Patients with in-treatment SBP lower than 130 mmHg and SBP between 131 and 141 mmHg were compared with patients with in-treatment SBP higher than 142 mmHg.

The results showed that during follow-up of a mean 4.6 years, new-onset AF was diagnosed in 7.9% of the patients. The researchers calculated that every 10-mmHg decrease in SBP was associated with a 13% lower risk of new-onset AF, and that those patients who achieved SBP of 125 mmHg had a 40% lower risk for AF. Compared with the group with less-adequate SBP control, patients with typical SBP control had a 24% lower risk of developing AF. The study was published online on June 8, 2015, in Hypertension.

“Among hypertensive patients at high risk of atrial fibrillation who can tolerate lower systolic blood pressure (SBP) levels, treating to a SBP of 130 or less may be able to reduce or retard the incidence of new AF,” said lead author Peter Okin, MD, of Weill Cornell Medical College, in an interview with Reuters. “But caution should be used when treating to these lower SBP levels to make sure that we are not harming patients in other ways.”

There is a well-established association between hypertension and increased risk for stroke, coronary heart disease, and renal failure. Another common cardiovascular condition is atrial fibrillation (AF), the most commonly occurring sustained cardiac arrhythmia, which is associated with a high mortality and morbidity rate from stroke, thromboembolism, and heart failure. Studies have shown that the risk of stroke doubles in patients with AF who also suffer from hypertension.

Related Links:

Weill Cornell Medical College
Ullevål Hospital



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.